HEADER IMMUNE SYSTEM 25-FEB-11 3QV4 TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF PEPTIDOGLYCAN RECOGNITION PROTEIN TITLE 2 (PGRP-S) WITH DIPEPTIDE L-ALA D-GLU AT 2.7 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDOGLYCAN RECOGNITION PROTEIN 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: PEPTIDOGLYCAN RECOGNITION PROTEIN SHORT, PGRP-S SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAMELUS DROMEDARIUS; SOURCE 3 ORGANISM_COMMON: CAMEL; SOURCE 4 ORGANISM_TAXID: 9838 KEYWDS IMMUNE RESPONSE, SECRETED, ANTIMICROBIAL, PGRP, ANTIBIOTIC, KEYWDS 2 PEPTIDOGLYCAN BINDING, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR P.K.SHUKLA,P.SHARMA,M.SINHA,P.KAUR,S.SHARMA,T.P.SINGH REVDAT 4 01-NOV-23 3QV4 1 HETSYN REVDAT 3 29-JUL-20 3QV4 1 COMPND REMARK HET HETNAM REVDAT 3 2 1 HETSYN FORMUL LINK SITE REVDAT 3 3 1 ATOM REVDAT 2 10-JUL-19 3QV4 1 REMARK LINK ATOM REVDAT 1 30-MAR-11 3QV4 0 JRNL AUTH P.K.SHUKLA,P.SHARMA,M.SINHA,P.KAUR,S.SHARMA,T.P.SINGH JRNL TITL CRYSTAL STRUCTURE OF THE COMPLEX OF PEPTIDOGLYCAN JRNL TITL 2 RECOGNITION PROTEIN (PGRP-S) WITH DIPEPTIDE L-ALA D-GLU AT JRNL TITL 3 2.7 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2573365.240 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 19429 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 993 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.75 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3060 REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE : 0.3280 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 139 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5348 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 109 REMARK 3 SOLVENT ATOMS : 273 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 20.60000 REMARK 3 B22 (A**2) : -15.42000 REMARK 3 B33 (A**2) : -5.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.240 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 29.24 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : LIG1.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : LIG1.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3QV4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000064141. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, AUTOMAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20422 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 48.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43600 REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3C2X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM POTASSIUM TARTRATE, 10% REMARK 280 PEG 3350, PH 7.2 , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.54350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.57400 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 81.84500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.54350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.57400 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 81.84500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.54350 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.57400 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 81.84500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.54350 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.57400 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 81.84500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA A 5 CB - CA - C ANGL. DEV. = 11.9 DEGREES REMARK 500 CYS A 6 CA - CB - SG ANGL. DEV. = -11.5 DEGREES REMARK 500 ALA C 94 N - CA - CB ANGL. DEV. = -10.4 DEGREES REMARK 500 PRO C 96 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 4 -135.78 -88.88 REMARK 500 ALA A 5 117.09 -34.66 REMARK 500 ALA A 92 45.43 -146.16 REMARK 500 ASP B 2 77.82 -163.66 REMARK 500 PRO B 3 106.56 -28.62 REMARK 500 PRO B 4 84.77 -12.25 REMARK 500 ALA B 5 -138.59 -134.36 REMARK 500 CYS B 6 -137.12 43.75 REMARK 500 ALA B 92 87.33 -161.04 REMARK 500 HIS B 93 -10.96 -156.78 REMARK 500 ALA B 94 37.13 -144.04 REMARK 500 SER B 139 -33.66 -29.01 REMARK 500 ASN B 140 58.07 -112.31 REMARK 500 GLN B 150 126.38 -170.20 REMARK 500 PRO B 151 95.78 -43.84 REMARK 500 HIS B 168 -1.50 -52.55 REMARK 500 PRO C 3 -136.96 -72.29 REMARK 500 PRO C 4 -157.78 -112.22 REMARK 500 ALA C 5 46.39 -98.84 REMARK 500 ALA C 39 14.97 55.03 REMARK 500 HIS C 93 -45.26 -130.20 REMARK 500 TYR C 111 40.88 -106.95 REMARK 500 PRO D 3 125.51 -19.34 REMARK 500 PRO D 4 -99.68 -2.46 REMARK 500 ALA D 5 38.10 87.63 REMARK 500 SER D 8 70.41 -113.05 REMARK 500 ALA D 17 119.66 -32.84 REMARK 500 ALA D 39 -10.36 59.70 REMARK 500 HIS D 93 -13.76 -143.41 REMARK 500 ALA D 94 52.22 -154.82 REMARK 500 PRO D 155 38.86 -95.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 5 CYS A 6 147.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ALA A 5 11.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 264 DISTANCE = 6.64 ANGSTROMS REMARK 525 HOH B 270 DISTANCE = 7.14 ANGSTROMS DBREF 3QV4 A 1 171 UNP Q9GK12 PGRP1_CAMDR 23 193 DBREF 3QV4 B 1 171 UNP Q9GK12 PGRP1_CAMDR 23 193 DBREF 3QV4 C 1 171 UNP Q9GK12 PGRP1_CAMDR 23 193 DBREF 3QV4 D 1 171 UNP Q9GK12 PGRP1_CAMDR 23 193 SEQRES 1 A 171 GLU ASP PRO PRO ALA CYS GLY SER ILE VAL PRO ARG ARG SEQRES 2 A 171 GLU TRP ARG ALA LEU ALA SER GLU CYS ARG GLU ARG LEU SEQRES 3 A 171 THR ARG PRO VAL ARG TYR VAL VAL VAL SER HIS THR ALA SEQRES 4 A 171 GLY SER HIS CYS ASP THR PRO ALA SER CYS ALA GLN GLN SEQRES 5 A 171 ALA GLN ASN VAL GLN SER TYR HIS VAL ARG ASN LEU GLY SEQRES 6 A 171 TRP CYS ASP VAL GLY TYR ASN PHE LEU ILE GLY GLU ASP SEQRES 7 A 171 GLY LEU VAL TYR GLU GLY ARG GLY TRP ASN ILE LYS GLY SEQRES 8 A 171 ALA HIS ALA GLY PRO THR TRP ASN PRO ILE SER ILE GLY SEQRES 9 A 171 ILE SER PHE MET GLY ASN TYR MET ASN ARG VAL PRO PRO SEQRES 10 A 171 PRO ARG ALA LEU ARG ALA ALA GLN ASN LEU LEU ALA CYS SEQRES 11 A 171 GLY VAL ALA LEU GLY ALA LEU ARG SER ASN TYR GLU VAL SEQRES 12 A 171 LYS GLY HIS ARG ASP VAL GLN PRO THR LEU SER PRO GLY SEQRES 13 A 171 ASP ARG LEU TYR GLU ILE ILE GLN THR TRP SER HIS TYR SEQRES 14 A 171 ARG ALA SEQRES 1 B 171 GLU ASP PRO PRO ALA CYS GLY SER ILE VAL PRO ARG ARG SEQRES 2 B 171 GLU TRP ARG ALA LEU ALA SER GLU CYS ARG GLU ARG LEU SEQRES 3 B 171 THR ARG PRO VAL ARG TYR VAL VAL VAL SER HIS THR ALA SEQRES 4 B 171 GLY SER HIS CYS ASP THR PRO ALA SER CYS ALA GLN GLN SEQRES 5 B 171 ALA GLN ASN VAL GLN SER TYR HIS VAL ARG ASN LEU GLY SEQRES 6 B 171 TRP CYS ASP VAL GLY TYR ASN PHE LEU ILE GLY GLU ASP SEQRES 7 B 171 GLY LEU VAL TYR GLU GLY ARG GLY TRP ASN ILE LYS GLY SEQRES 8 B 171 ALA HIS ALA GLY PRO THR TRP ASN PRO ILE SER ILE GLY SEQRES 9 B 171 ILE SER PHE MET GLY ASN TYR MET ASN ARG VAL PRO PRO SEQRES 10 B 171 PRO ARG ALA LEU ARG ALA ALA GLN ASN LEU LEU ALA CYS SEQRES 11 B 171 GLY VAL ALA LEU GLY ALA LEU ARG SER ASN TYR GLU VAL SEQRES 12 B 171 LYS GLY HIS ARG ASP VAL GLN PRO THR LEU SER PRO GLY SEQRES 13 B 171 ASP ARG LEU TYR GLU ILE ILE GLN THR TRP SER HIS TYR SEQRES 14 B 171 ARG ALA SEQRES 1 C 171 GLU ASP PRO PRO ALA CYS GLY SER ILE VAL PRO ARG ARG SEQRES 2 C 171 GLU TRP ARG ALA LEU ALA SER GLU CYS ARG GLU ARG LEU SEQRES 3 C 171 THR ARG PRO VAL ARG TYR VAL VAL VAL SER HIS THR ALA SEQRES 4 C 171 GLY SER HIS CYS ASP THR PRO ALA SER CYS ALA GLN GLN SEQRES 5 C 171 ALA GLN ASN VAL GLN SER TYR HIS VAL ARG ASN LEU GLY SEQRES 6 C 171 TRP CYS ASP VAL GLY TYR ASN PHE LEU ILE GLY GLU ASP SEQRES 7 C 171 GLY LEU VAL TYR GLU GLY ARG GLY TRP ASN ILE LYS GLY SEQRES 8 C 171 ALA HIS ALA GLY PRO THR TRP ASN PRO ILE SER ILE GLY SEQRES 9 C 171 ILE SER PHE MET GLY ASN TYR MET ASN ARG VAL PRO PRO SEQRES 10 C 171 PRO ARG ALA LEU ARG ALA ALA GLN ASN LEU LEU ALA CYS SEQRES 11 C 171 GLY VAL ALA LEU GLY ALA LEU ARG SER ASN TYR GLU VAL SEQRES 12 C 171 LYS GLY HIS ARG ASP VAL GLN PRO THR LEU SER PRO GLY SEQRES 13 C 171 ASP ARG LEU TYR GLU ILE ILE GLN THR TRP SER HIS TYR SEQRES 14 C 171 ARG ALA SEQRES 1 D 171 GLU ASP PRO PRO ALA CYS GLY SER ILE VAL PRO ARG ARG SEQRES 2 D 171 GLU TRP ARG ALA LEU ALA SER GLU CYS ARG GLU ARG LEU SEQRES 3 D 171 THR ARG PRO VAL ARG TYR VAL VAL VAL SER HIS THR ALA SEQRES 4 D 171 GLY SER HIS CYS ASP THR PRO ALA SER CYS ALA GLN GLN SEQRES 5 D 171 ALA GLN ASN VAL GLN SER TYR HIS VAL ARG ASN LEU GLY SEQRES 6 D 171 TRP CYS ASP VAL GLY TYR ASN PHE LEU ILE GLY GLU ASP SEQRES 7 D 171 GLY LEU VAL TYR GLU GLY ARG GLY TRP ASN ILE LYS GLY SEQRES 8 D 171 ALA HIS ALA GLY PRO THR TRP ASN PRO ILE SER ILE GLY SEQRES 9 D 171 ILE SER PHE MET GLY ASN TYR MET ASN ARG VAL PRO PRO SEQRES 10 D 171 PRO ARG ALA LEU ARG ALA ALA GLN ASN LEU LEU ALA CYS SEQRES 11 D 171 GLY VAL ALA LEU GLY ALA LEU ARG SER ASN TYR GLU VAL SEQRES 12 D 171 LYS GLY HIS ARG ASP VAL GLN PRO THR LEU SER PRO GLY SEQRES 13 D 171 ASP ARG LEU TYR GLU ILE ILE GLN THR TRP SER HIS TYR SEQRES 14 D 171 ARG ALA HET NAG E 1 15 HET NAG E 2 14 HET NAG E 3 14 HET GOL A 172 6 HET GOL A 173 6 HET GOL A 174 6 HET GOL A 175 6 HET EDO A3318 4 HET PEG B6073 7 HET ALA C2991 5 HET DGL C2992 10 HET SRT D 172 10 HET GOL D 503 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GOL GLYCEROL HETNAM EDO 1,2-ETHANEDIOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM ALA ALANINE HETNAM DGL D-GLUTAMIC ACID HETNAM SRT S,R MESO-TARTARIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 5 NAG 3(C8 H15 N O6) FORMUL 6 GOL 5(C3 H8 O3) FORMUL 10 EDO C2 H6 O2 FORMUL 11 PEG C4 H10 O3 FORMUL 12 ALA C3 H7 N O2 FORMUL 13 DGL C5 H9 N O4 FORMUL 14 SRT C4 H6 O6 FORMUL 16 HOH *273(H2 O) HELIX 1 1 PRO A 11 ARG A 16 5 6 HELIX 2 2 THR A 45 ASN A 63 1 19 HELIX 3 3 TRP A 98 PRO A 100 5 3 HELIX 4 4 PRO A 117 LEU A 134 1 18 HELIX 5 5 HIS A 146 GLN A 150 1 5 HELIX 6 6 GLY A 156 GLN A 164 1 9 HELIX 7 7 ARG B 12 ARG B 16 5 5 HELIX 8 8 THR B 45 ARG B 62 1 18 HELIX 9 9 ALA B 94 ASN B 99 1 6 HELIX 10 10 PRO B 117 ALA B 133 1 17 HELIX 11 11 GLY B 156 TRP B 166 1 11 HELIX 12 12 PRO C 11 ARG C 16 1 6 HELIX 13 13 THR C 45 ASN C 63 1 19 HELIX 14 14 ALA C 94 ASN C 99 1 6 HELIX 15 15 PRO C 117 LEU C 134 1 18 HELIX 16 16 ARG C 147 VAL C 149 5 3 HELIX 17 17 GLY C 156 GLN C 164 1 9 HELIX 18 18 ARG D 12 ARG D 16 5 5 HELIX 19 19 THR D 45 ASN D 63 1 19 HELIX 20 20 ALA D 94 ASN D 99 1 6 HELIX 21 21 PRO D 117 LEU D 134 1 18 HELIX 22 22 ARG D 147 VAL D 149 5 3 HELIX 23 23 GLY D 156 GLN D 164 1 9 SHEET 1 A 5 VAL A 81 GLU A 83 0 SHEET 2 A 5 PHE A 73 ILE A 75 -1 N LEU A 74 O TYR A 82 SHEET 3 A 5 SER A 102 PHE A 107 1 O SER A 106 N ILE A 75 SHEET 4 A 5 VAL A 30 HIS A 37 1 N SER A 36 O PHE A 107 SHEET 5 A 5 LEU A 137 GLY A 145 1 O GLU A 142 N ARG A 31 SHEET 1 B 5 VAL B 81 GLU B 83 0 SHEET 2 B 5 PHE B 73 ILE B 75 -1 N LEU B 74 O TYR B 82 SHEET 3 B 5 SER B 102 PHE B 107 1 O SER B 106 N ILE B 75 SHEET 4 B 5 VAL B 30 HIS B 37 1 N TYR B 32 O ILE B 103 SHEET 5 B 5 LEU B 137 GLY B 145 1 O GLU B 142 N ARG B 31 SHEET 1 C 6 ILE C 9 VAL C 10 0 SHEET 2 C 6 VAL C 81 GLU C 83 1 O VAL C 81 N VAL C 10 SHEET 3 C 6 PHE C 73 ILE C 75 -1 N LEU C 74 O TYR C 82 SHEET 4 C 6 SER C 102 PHE C 107 1 O SER C 106 N ILE C 75 SHEET 5 C 6 VAL C 30 HIS C 37 1 N VAL C 34 O ILE C 103 SHEET 6 C 6 LEU C 137 GLY C 145 1 O LYS C 144 N VAL C 33 SHEET 1 D 6 ILE D 9 VAL D 10 0 SHEET 2 D 6 VAL D 81 GLU D 83 1 O VAL D 81 N VAL D 10 SHEET 3 D 6 PHE D 73 ILE D 75 -1 N LEU D 74 O TYR D 82 SHEET 4 D 6 SER D 102 PHE D 107 1 O SER D 106 N ILE D 75 SHEET 5 D 6 VAL D 30 HIS D 37 1 N SER D 36 O ILE D 105 SHEET 6 D 6 LEU D 137 GLY D 145 1 O ARG D 138 N VAL D 30 SSBOND 1 CYS A 6 CYS A 130 1555 1555 2.04 SSBOND 2 CYS A 22 CYS A 67 1555 1555 2.03 SSBOND 3 CYS A 43 CYS A 49 1555 1555 2.05 SSBOND 4 CYS B 6 CYS B 130 1555 1555 2.04 SSBOND 5 CYS B 22 CYS B 67 1555 1555 2.04 SSBOND 6 CYS B 43 CYS B 49 1555 1555 2.05 SSBOND 7 CYS C 6 CYS C 130 1555 1555 2.03 SSBOND 8 CYS C 22 CYS C 67 1555 1555 2.04 SSBOND 9 CYS C 43 CYS C 49 1555 1555 2.05 SSBOND 10 CYS D 6 CYS D 130 1555 1555 2.03 SSBOND 11 CYS D 22 CYS D 67 1555 1555 2.04 SSBOND 12 CYS D 43 CYS D 49 1555 1555 2.03 LINK C ALA C2991 N DGL C2992 1555 1555 1.33 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O4 NAG E 2 C1 NAG E 3 1555 1555 1.36 CISPEP 1 ARG A 28 PRO A 29 0 0.32 CISPEP 2 SER A 154 PRO A 155 0 0.15 CISPEP 3 ARG B 28 PRO B 29 0 1.39 CISPEP 4 SER B 154 PRO B 155 0 0.42 CISPEP 5 PRO C 3 PRO C 4 0 -0.22 CISPEP 6 ARG C 28 PRO C 29 0 0.31 CISPEP 7 SER C 154 PRO C 155 0 1.24 CISPEP 8 ARG D 28 PRO D 29 0 0.18 CISPEP 9 SER D 154 PRO D 155 0 0.11 CRYST1 89.087 101.148 163.690 90.00 90.00 90.00 I 2 2 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011225 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009887 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006109 0.00000